+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-05-18Number of Pages: 192

Hospital Pharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023

Table of Content

1. Preface
    1.1. Report Description
    1.2. Market Segmentation
    1.3. Research Methodology
    1.4. Assumptions

2. Executive Summary
    2.1. Global Hospital Pharmaceuticals Market Revenue, by Therapeutic Area, 2014 & 2023 (US$ Mn)
    2.2. Global Hospital Pharmaceuticals Market Revenue, by Countries, 2014 (US$ Mn)
    2.3. Global Hospital Pharmaceuticals Market Revenue, by Geography, 2014 & 2023 (US$ Mn)
    2.4. Global Hospital Pharmaceuticals Market, 2014 & 2023: Market Snapshot 

3. Global Hospital Pharmaceuticals Market – Industry Analysis
    3.1. Introduction
    3.2. Market Dynamics
          3.2.1. Drivers
                  3.2.1.1. Driver 1 - Increased emergency department visits drive demand for hospital drugs
                  3.2.1.2. Driver 2 - Rise in spending on medicines
                  3.2.1.3. Driver 3 - High prevalence of diseases across the world
                  3.2.1.4. Driver 4- Trend towards increase in use of telemedicine technology by hospitals
          3.2.2. Restraints
                  3.2.2.1. Restraint 1- Patent Expirations of Blockbuster Drugs
                  3.2.2.2. Restraint 2- Shift toward use of home health care services
          3.2.3. Opportunities
                  3.2.3.1. Opportunity 1- Extensive R&D activities lead to introduction of new drugs in market
                  3.2.3.2. Opportunity 2- Increasing no. of hospitals in developing economies
    3.3. Event Impact Analysis
    3.4. Value Chain Analysis
    3.5. Market Attractiveness Analysis: Global Hospital Pharmaceuticals Market
    3.6. Market Share Analysis: Global Hospital Pharmaceuticals Market, by Key Players, 2013 (Value %)

4. Market Segmentation – By Product Type
    4.1. Introduction
          4.1.1. Global Hospital Pharmaceuticals Market Revenue, by Major Therapeutic Area, (U.S. $ Mn), 2013-2023
    4.2. Cardiology
          4.2.1. Introduction
          4.2.2. Global Cardiology Hospital Pharmaceuticals Market Revenue, by Therapeutic Class, (US$ Mn), 2013-2023
          4.2.3. Global Antihypertensive Drugs Market Revenue, (US$ Mn), 2013-2023
          4.2.4. Global Dyslipidemia Drugs Market Revenue, (US$ Mn), 2013-2023
          4.2.5. Global Other Cardiology Drugs Market Revenue, (US$ Mn), 2013-2023
    4.3. Oncology
          4.3.1. Introduction
          4.3.2. Global Oncology Hospital Pharmaceuticals Market Revenue, by Therapeutic Class, (US$ Mn), 2013-2023
          4.3.3. Global Immunomodulating Agents Market Revenue, (US$ Mn), 2013-2023
          4.3.4. Global Alkylating Agents Market Revenue, (US$ Mn), 2013-2023
          4.3.5. Global Anti-metabolites Market Revenue, (US$ Mn), 2013-2023
          4.3.6. Global Hormonal Agents Market Revenue, (US$ Mn), 2013-2023
          4.3.7. Global Miscellaneous Oncology Drugs Market Revenue, (US$ Mn), 2013-2023
    4.4. Nephrology and Urology
          4.4.1. Introduction
          4.4.2. Global Nephrology and Urology Hospital Pharmaceuticals Market Revenue, by Therapeutic Classs, (US$ Mn), 2013-2023
          4.4.3. Global Diuretics Market Revenue, (US$ Mn), 2013-2023
          4.4.4. Global Anti-Hypertensives Market Revenue, (US$ Mn), 2013-2023
          4.4.5. Global Phosphate Binders Market Revenue, (US$ Mn), 2013-2023
          4.4.6. Global Anti-Cholinergics Market Revenue, (US$ Mn), 2013-2023
          4.4.7. Global 5-alpha-reductase Inhibitors Market Revenue, (US$ Mn), 2013-2023
    4.5. Neurology
          4.5.1. Introduction
          4.5.2. Global Neurology Hospital Pharmaceuticals Market Revenue, by Therapeutic Class, (US$ Mn), 2013-2023
          4.5.3. Global Diuretics Market Revenue, (US$ Mn), 2013-2023
          4.5.4. Global Anti-Anxiety Market Revenue, (US$ Mn), 2013-2023
          4.5.5. Global Anti-Migraine Market Revenue, (US$ Mn), 2013-2023
          4.5.6. Global Anti-Depressant Market Revenue, (US$ Mn), 2013-2023
          4.5.7. Global Anti-Psychotics Market Revenue, (US$ Mn), 2013-2023
    4.6. Pain
          4.6.1. Introduction
          4.6.2. Global Pain Hospital Pharmaceuticals Market Revenue, by Therapeutic Class, (US$ Mn), 2013-2023
          4.6.3. Global Anti-Convulsants Market Revenue, (US$ Mn), 2013-2023
          4.6.4. Global Anesthetics Market Revenue, (US$ Mn), 2013-2023
          4.6.5. Global NSAID's Market Revenue, (US$ Mn), 2013-2023
          4.6.6. Global Opioids Market Revenue, (US$ Mn), 2013-2023
          4.6.7. Global Non-Narcotic Agents Market Revenue, (US$ Mn), 2013-2023
    4.7. Infection
          4.7.1. Introduction
          4.7.2. Global Infection Hospital Pharmaceuticals Market Revenue, by Therapeutic Class, (US$ Mn), 2013-2023
          4.7.3. Global Anti-Bacterial Drugs Market Revenue, (US$ Mn), 2013-2023
          4.7.4. Global Anti-Viral Drugs Market Revenue, (US$ Mn), 2013-2023
          4.7.5. Global Anti-Fungal Drugs Market Revenue, (US$ Mn), 2013-2023
          4.7.6. Global Anti-Parasite Drugs Market Revenue, (US$ Mn), 2013-2023

5. Market Segmentation – By Indication
    5.1. Introduction
          5.1.1. Global Hospital Pharmaceuticals Market Revenue, by Indication, (US$ Mn), 2013-2023
    5.2. Cardiology
          5.2.1. Global Cardiology Hospital Pharmaceuticals Market Revenue, by Indications, (US$ Mn), 2013-2023
          5.2.2. Global Coronary Heart Disease Market Revenue, (US$ Mn), 2013-2023
          5.2.3. Global Stroke Market Revenue, (US$ Mn), 2013-2023
          5.2.4. Global High Blood Pressure Market Revenue, (US$ Mn), 2013-2023
          5.2.5. Global Heart Failure Market Revenue, (US$ Mn), 2013-2023
          5.2.6. Global Other Cardiology Indications Market Revenue, (US$ Mn), 2013-2023
    5.3. Oncology
          5.3.1. Global Oncology Hospital Pharmaceuticals Market Revenue, by Indications, (US$ Mn), 2013-2023
          5.3.2. Global Lung Cancer Market Revenue, (US$ Mn), 2013-2023
          5.3.3. Global Breast Cancer Market Revenue, (US$ Mn), 2013-2023
          5.3.4. Global Colorectal Cancer Market Revenue, (US$ Mn), 2013-2023
          5.3.5. Global Prostate Cancer Market Revenue, (US$ Mn), 2013-2023
          5.3.6. Global Other Oncology Indications Market Revenue, (US$ Mn), 2013-2023
    5.4. Nephrology and Urology
          5.4.1. Global Nephrology and Urology Hospital Pharmaceuticals Market Revenue, by Indication, (US$ Mn), 2013-2023
          5.4.2. Global Acute Kidney Failure Market Revenue, (US$ Mn), 2013-2023
          5.4.3. Global Chronic Kidney Diseases Market Revenue, (US$ Mn), 2013-2023
          5.4.4. Global Glomerular Diseases Market Revenue, (US$ Mn), 2013-2023
          5.4.5. Global Diabetes Market Revenue, (US$ Mn), 2013-2023
          5.4.6. Global Other Nephrology and Urology Indications Market Revenue, (US$ Mn), 2013-2023
    5.5. Neurology
          5.5.1. Global Neurology Hospital Pharmaceuticals Market Revenue, by Indication, (US$ Mn), 2013-2023
          5.5.2. Global Epilepsy Market Revenue, (US$ Mn), 2013-2023
          5.5.3. Global Alzheimer's Disease Market Revenue, (US$ Mn), 2013-2023
          5.5.4. Global Parkinson's Disease Market Revenue, (US$ Mn), 2013-2023
          5.5.5. Global Multiple Sclerosis Market Revenue, (US$ Mn), 2013-2023
          5.5.6. Global Stroke Market Revenue, (US$ Mn), 2013-2023
          5.5.7. Global Other Neurology Indications Market Revenue, (US$ Mn), 2013-2023
    5.6. Pain
          5.6.1. Global Pain Hospital Pharmaceuticals Market Revenue, by Indication, (US$ Mn), 2013-2023
          5.6.2. Global Neuropathic Pain Market Revenue, (US$ Mn), 2013-2023
          5.6.3. Global Fibromyalgia Market Revenue, (US$ Mn), 2013-2023
          5.6.4. Global Osteoarthritis Market Revenue, (US$ Mn), 2013-2023
          5.6.5. Global Rheumatoid Arthritis Market Revenue, (US$ Mn), 2013-2023
          5.6.6. Global Cancer Pain Market Revenue, (US$ Mn), 2013-2023
          5.6.7. Global Other Pain Indications Market Revenue, (US$ Mn), 2013-2023
    5.7. Infection
          5.7.1. Global Infection Hospital Pharmaceuticals Market Revenue, by Indication, (US$ Mn), 2013-2023
          5.7.2. Global Tuberculosis Market Revenue, (US$ Mn), 2013-2023
          5.7.3. Global Pneumonia Market Revenue, (US$ Mn), 2013-2023
          5.7.4. Global Hepatitis A Market Revenue, (US$ Mn), 2013-2023
          5.7.5. Global Hepatitis B Market Revenue, (US$ Mn), 2013-2023
          5.7.6. Global Candida Infection Market Revenue, (US$ Mn), 2013-2023
          5.7.7. Global Fungal Meningitis Market Revenue, (US$ Mn), 2013-2023
          5.7.8. Global Shigellosis Market Revenue, (US$ Mn), 2013-2023
          5.7.9. Global Amoebiasis Market Revenue, (US$ Mn), 2013-2023
          5.7.10. Global Other Infection Indications Market Revenue, (US$ Mn), 2013-2023

6. Market Segmentation – By Geography
    6.1. Global Hospital Pharmaceuticals Market Revenue, by Geography, (US$ Mn), 2013-2023
    6.2. North America Hospital Pharmaceuticals Market Revenue, (US$ Mn), 2013-2023
          6.2.1. U.S. Hospital Pharmaceuticals Market Revenue, (US$ Mn), 2013-2023
          6.2.2. Canada Hospital Pharmaceuticals Market Revenue, (US$ Mn), 2013-2023
    6.3. Europe Hospital Pharmaceuticals Market Revenue, (US$ Mn), 2013-2023
          6.3.1. U.K. Hospital Pharmaceuticals Market Revenue, (US$ Mn), 2013-2023
          6.3.2. Germany Hospital Pharmaceuticals Market Revenue, (US$ Mn), 2013-2023
          6.3.3. Rest of Europe Hospital Pharmaceuticals Market Revenue, (US$ Mn), 2013-2023
    6.4. Asia Pacific Hospital Pharmaceuticals Market Revenue, (US$ Mn), 2013-2023
          6.4.1. China Hospital Pharmaceuticals Market Revenue, (US$ Mn), 2013-2023
          6.4.2. Japan Hospital Pharmaceuticals Market Revenue, (US$ Mn), 2013-2023
          6.4.3. Rest of Asia Pacific Hospital Pharmaceuticals Market Revenue, (US$ Mn), 2013-2023
    6.5. Latin America Hospital Pharmaceuticals Market Revenue, (US$ Mn), 2013-2023
          6.5.1. Brazil Hospital Pharmaceuticals Market Revenue, (US$ Mn), 2013-2023
          6.5.2. Mexico Hospital Pharmaceuticals Market Revenue, (US$ Mn), 2013-2023
          6.5.3. Rest of Latin America Hospital Pharmaceuticals Market Revenue, (US$ Mn), 2013-2023
    6.6. Rest of the World Hospital Pharmaceuticals Market Revenue, (US$ Mn), 2013-2023

7. Company Profiles
    7.1. AztraZeneca plc
    7.2. Bayer AG
    7.3. Bristol-Myers Squibb Company
    7.4. Eli Lilly and Company
    7.5. GlaxoSmithKline plc
    7.6. Johnson and Johnson
    7.7. Merck and Co., Inc.
    7.8. Novartis AG
    7.9. Pfizer, Inc.
    7.10. Sanofi-Aventis

List of Figures

FIG. 1 Global Teleradiology Market Share, by Geography, 2014 (Value %)
FIG. 2 Hospital Pharmaceuticals Market Segmentation
FIG. 3 Global Hospital Pharmaceuticals Market, by Therapeutic Area, 2014 & 2023 (US$ Million)
FIG. 4 Global Hospital Pharmaceuticals Market Revenue, by Countries, 2014 (US$ Mn)
FIG. 5 Comparative Analysis: Global Hospital Pharmaceuticals Market, by Geography, 2014 & 2023 (Value %)
FIG. 6 Global Hospital Pharmaceutical Market, Value Chain Analysis
FIG. 7 Market Attractiveness Analysis: Global Hospital Pharmaceutical Market, by Geography, 2014
FIG. 8 Market Share Analysis: Global Hospital Pharmaceutical Market, by Key Players, 2014 (Value %)
FIG. 9 Global Hospital Pharmaceuticals Market, Cardiology Segmentation 
FIG. 10 Global Cardiology Hospital Pharmaceuticals Market Revenue, by Therapeutic Class, 2013-2023 (US$ Mn)
FIG. 11 Global Hospital Pharmaceuticals Market, Oncology Segmentation 
FIG. 12 Global Oncology Hospital Pharmaceuticals Market Revenue, by Therapeutic Class, 2013-2023 (US$ Mn)
FIG. 13 Global Hospital Pharmaceuticals Market, Nephrology and Urology segmentation
FIG. 14 Global Nephrology Hospital Pharmaceuticals Market Revenue, by Therapeutic Class, 2013-2023 (US$ Mn)
FIG. 15 Global Hospital Pharmaceuticals Market, Neurology Segmentation
FIG. 16 Global Neurology Hospital Pharmaceuticals Market Revenue, by Therapeutic Class, 2013-2023 (US$ Mn)
FIG. 17 Global Hospital Pharmaceuticals Market, Pain Segmentation 
FIG. 18 Global Pain Hospital Pharmaceuticals Market Revenue, by Therapeutic Class, 2013-2023 (US$ Mn)
FIG. 19 Global Hospital Pharmaceuticals Market, Infection Segmentation
FIG. 20 Global Infection Hospital Pharmaceuticals Market Revenue, by Therapeutic Class, 2013-2023 (US$ Mn)
FIG. 21 Global Hospital Pharmaceuticals Market, segmentation by Indication
FIG. 22 Global Cardiology Hospital Pharmaceuticals Market Revenue, by Indications, (US$ Mn), 2013-2023
FIG. 23 Global Oncology Hospital Pharmaceuticals Market Revenue, by Indications, (US$ Mn), 2013-2023
FIG. 24 Global Nephrology and Urology Hospital Pharmaceuticals Market Revenue, by Indications, (US$ Mn), 2013-2023
FIG. 25 Global Neurology Hospital Pharmaceuticals Market Revenue, by Indications, (US$ Mn), 2013-2023
FIG. 26 Global Pain Hospital Pharmaceuticals Market Revenue, by Indications, (US$ Mn), 2013-2023
FIG. 27 Global Infection Hospital Pharmaceuticals Market Revenue, by Indications, (US$ Mn), 2013-2023
FIG. 28 Comparative Analysis: Global Hospital Pharmaceuticals Market Revenue, by Geography (Value %), 2014 & 2023
FIG. 29 North America Hospital Pharmaceuticals Market Revenue, (US$ Mn), 2013-2023
FIG. 30 Europe Hospital Pharmaceuticals Market Revenue, (US$ Mn), 2013-2023
FIG. 31 Asia Pacific Hospital Pharmaceuticals Market Revenue, (US$ Mn), 2013-2023
FIG. 32 Latin America Hospital Pharmaceuticals Market Revenue, (US$ Mn), 2013-2023
FIG. 33 Rest of the World Hospital Pharmaceuticals Market Revenue, (US$ Mn), 2013-2023
FIG. 34 AstraZeneca plc: Annual Revenue, 2012 – 2014 (US$ Million)
FIG. 35 Bayer AG Annual Revenue: 2012 – 2014 (US$ Million)
FIG. 36 Bristol-Myers Squibb Company: Annual Revenue, 2012 – 2014 (US$ Million)
FIG. 37 Eli Lilly and Company: Annual Revenue, 2012 – 2014 (US$ Million)
FIG. 38 GlaxoSmithKline plc: Annual Revenue, 2012 – 2014 (US$ Million)
FIG. 39 Johnson & Johnson: Annual Revenue, 2012– 2014 (US$ Million)
FIG. 40 Merck & Co., Inc.: Annual Revenue, 2012 – 2014 (US$ Million)
FIG. 41 Novartis AG Annual Revenue: 2012 – 2014 (US$ Million)
FIG. 42 Pfizer, Inc.: Annual Revenue 2012 – 2014 (US$ Million)
FIG. 43 Sanofi: Annual Revenue, 2012 – 2014 (US$ Million)

 

List of Tables

TABLE 1 Market Snapshot: Global Hospital Pharmaceuticals Market
TABLE 2 Major Patent Expirations in Forecast Period
TABLE 3 Event Impact Analysis: Hospital Pharmaceutical Market
TABLE 4 Global Hospital Pharmaceuticals Market Revenue, by Major Therapeutic Areas, 2013-2023 (US$ Million)
TABLE 5 Cardiology Pipeline Overview
TABLE 6 Oncology Pipeline Overview
TABLE 7 Nephrology and Urology Pipeline Overview
TABLE 8 Neurology Pipeline Overview
TABLE 9 Pain Pipeline Overview
TABLE 10 Infection Pipeline Overview
TABLE 11 Global Hospital Pharmaceuticals Market Revenue, by Indication, (US$ Mn), 2013-2023
TABLE 12 Global Hospital Pharmaceuticals Market Revenue, by Geography, (US$ Mn), 2013-2023


 
 
Back To Top